A non-viral plasmid DNA delivery system consisting on a lysine-derived cationic lipid mixed with a fusogenic lipid
dc.contributor.author | Martínez Negro, María | |
dc.contributor.author | Sánchez Arribas, Natalia | |
dc.contributor.author | Guerrero Martínez, Andrés | |
dc.contributor.author | Moya, Mª Luisa | |
dc.contributor.author | Tros de Ilarduya, Conchita | |
dc.contributor.author | Mendicuti, Francisco | |
dc.contributor.author | Aicart Sospedra, Emilio | |
dc.contributor.author | Junquera González, María Elena | |
dc.date.accessioned | 2024-10-16T07:34:48Z | |
dc.date.available | 2024-10-16T07:34:48Z | |
dc.date.issued | 2019 | |
dc.description | PORTADA DE REVISTA | |
dc.description.abstract | The insertion of biocompatible amino acid moieties in non-viral gene nanocarriers is an attractive approach that has been recently gaining interest. In this work, a cationic lipid, consisting of a lysine-derived moiety linked to a C12 chain (LYCl) was combined with a common fusogenic helper lipid (DOPE) and evaluated as a potential vehicle to transfect two plasmid DNAs (encoding green fluorescent protein GFP and luciferase) into COS-7 cells. A multidisciplinary approach has been followed: (i) biophysical characterization based on zeta potential, gel electrophoresis, small-angle X-ray scattering (SAXS), and cryo-transmission electronic microscopy (cryo-TEM); (ii) biological studies by fluorescence assisted cell sorting (FACS), luminometry, and cytotoxicity experiments; and (iii) a computational study of the formation of lipid bilayers and their subsequent stabilization with DNA. The results indicate that LYCl/DOPE nanocarriers are capable of compacting the pDNAs and protecting them efficiently against DNase I degradation, by forming Lalfa lyotropic liquid crystal phases, with an average size of ~200 nm and low polydispersity that facilitate the cellular uptake process. The computational results confirmed that the LYCl/DOPE lipid bilayers are stable and also capable of stabilizing DNA fragments via lipoplex formation, with dimensions consistent with experimental values. The optimum formulations (found at 20% of LYCl content) were able to complete the transfection process efficiently and with high cell viabilities, even improving the outcomes of the positive control Lipo2000*. | |
dc.description.department | Depto. de Química Física | |
dc.description.faculty | Fac. de Ciencias Químicas | |
dc.description.fundingtype | Descuento UCM | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | Ministerio de Ciencia, Innovación y Universidades | |
dc.description.sponsorship | Universidad Complutense de Madrid | |
dc.description.sponsorship | Universidad de Alcalá | |
dc.description.status | pub | |
dc.identifier.citation | Martínez-Negro M, Sánchez-Arribas N, Guerrero-Martínez A, Moyá ML, Tros De Ilarduya C, Mendicuti F, et al. A Non-Viral Plasmid DNA Delivery System Consisting on a Lysine-Derived Cationic Lipid Mixed with a Fusogenic Lipid. Pharmaceutics 2019;11:632. https://doi.org/10.3390/pharmaceutics11120632 | |
dc.identifier.doi | 10.3390/pharmaceutics11120632 | |
dc.identifier.issn | 1999-4923 | |
dc.identifier.officialurl | https://doi:10.3390/pharmaceutics11120632 | |
dc.identifier.relatedurl | www.mdpi.com/journal/pharmaceutics | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/108996 | |
dc.journal.title | Pharmaceutics | |
dc.language.iso | eng | |
dc.page.initial | 632 | |
dc.relation.projectID | info:eu-repo/grantAgreement/MEC//CTQ2015-65972-R | |
dc.relation.projectID | info:eu-repo/grantAgreement/MEC//CTQ2015-64425-C2-1-R | |
dc.relation.projectID | info:eu-repo/grantAgreement/MEC//CTQ2015-64425-C2-2-R | |
dc.relation.projectID | info:eu-repo/grantAgreement/MEC//CTQ2016-80600-P | |
dc.relation.projectID | info:eu-repo/grantAgreement/MICINN//RTI2018-095844-B-I00 | |
dc.relation.projectID | info:eu-repo/grantAgreement/MEC//UCMA05-33-010 | |
dc.relation.projectID | info:eu-repo/grantAgreement/MEC//CCGP2017-EXP/027 | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject.cdu | 544 | |
dc.subject.keyword | Lysine-derived cationic lipid | |
dc.subject.keyword | Plasmid DNA | |
dc.subject.keyword | Lipoplexes | |
dc.subject.keyword | Transfection | |
dc.subject.keyword | Protection | |
dc.subject.keyword | Compaction | |
dc.subject.keyword | Gene delivery | |
dc.subject.keyword | Multilamellar aggregates | |
dc.subject.keyword | Molecular dynamics | |
dc.subject.ucm | Química física (Química) | |
dc.subject.unesco | 2307 Química Física | |
dc.title | A non-viral plasmid DNA delivery system consisting on a lysine-derived cationic lipid mixed with a fusogenic lipid | |
dc.type | journal article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 11 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | b21e6658-9ad1-4fed-bbf1-e41299c40c84 | |
relation.isAuthorOfPublication | d590ed92-7a5f-481b-abb0-42ad5d4dbd42 | |
relation.isAuthorOfPublication | 22761001-a3ad-4b9e-b47f-bfd3ba5f8a57 | |
relation.isAuthorOfPublication | 56e24a94-c784-43f3-8f0b-19917deee155 | |
relation.isAuthorOfPublication | 3d4e45e9-f8ae-4547-8194-1b781fcec865 | |
relation.isAuthorOfPublication.latestForDiscovery | b21e6658-9ad1-4fed-bbf1-e41299c40c84 |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- Pharmaceutics_LYCL_DOPE_pDNA_2019.pdf
- Size:
- 1.65 MB
- Format:
- Adobe Portable Document Format